Alcon Inc. Ordinary Shares

ALC XNYS

Market Cap

31B

Short interest (May 15)

1.2%

Borrow Fee

0.54%

↓ 21.5%

Available Shares

200K

↓ 43.6%

Price Chart

Company Overview

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Company Info

Exchange: NYSE
CIK: 0001167379
Asset Type: CS

Market Data

Market Cap: $31,349,356,000
Employees: 25,942
Status: Active

Short Interest

Current Borrow Fee 0.54%
Range: 0.54% - 0.66%
Available Shares 200K
Range: 90K - 400K

Recent Changes

Fee Change: ↓ 9.8%
Available Change: ↑ 79.1%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime